238 related articles for article (PubMed ID: 27730741)
1. Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit.
Yue MC; Collins JT; Subramoniapillai E; Kennedy GA
Asia Pac J Clin Oncol; 2017 Feb; 13(1):37-43. PubMed ID: 27730741
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study.
Vu D; Peck AJ; Nichols WG; Varley C; Englund JA; Corey L; Boeckh M
Clin Infect Dis; 2007 Jul; 45(2):187-93. PubMed ID: 17578777
[TBL] [Abstract][Full Text] [Related]
3. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.
Lee VJ; Yap J; Cook AR; Chen MI; Tay JK; Tan BH; Loh JP; Chew SW; Koh WH; Lin R; Cui L; Lee CW; Sung WK; Wong CW; Hibberd ML; Kang WL; Seet B; Tambyah PA
N Engl J Med; 2010 Jun; 362(23):2166-74. PubMed ID: 20558367
[TBL] [Abstract][Full Text] [Related]
4. Pandemic A/H1N1/2009 influenza in a paediatric haematology and oncology unit: successful management of a sudden outbreak.
Buchbinder N; Dumesnil C; Pinquier D; Merle V; Filhon B; Schneider P; Vannier JP
J Hosp Infect; 2011 Oct; 79(2):155-60. PubMed ID: 21783276
[TBL] [Abstract][Full Text] [Related]
5. Control of an H1N1 outbreak in a correctional facility in central Taiwan.
Chao WC; Liu PY; Wu CL
J Microbiol Immunol Infect; 2017 Apr; 50(2):175-182. PubMed ID: 26051221
[TBL] [Abstract][Full Text] [Related]
6. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.
Reid G; Huprikar S; Patel G; Razonable RR; Mossad S; Levi M; Gregg K; Shoham S; Humar A; Adams W; Kumar D
Transpl Infect Dis; 2013 Oct; 15(5):487-92. PubMed ID: 23890293
[TBL] [Abstract][Full Text] [Related]
7. Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave.
Fanella ST; Pinto MA; Bridger NA; Bullard JM; Coombs JM; Crockett ME; Olekson KL; Poliquin PG; Van Caeseele PG; Embree JE
Infect Control Hosp Epidemiol; 2011 May; 32(5):435-43. PubMed ID: 21515973
[TBL] [Abstract][Full Text] [Related]
8. Influenza A/H1N1/2009 outbreak in a neonatal intensive care unit.
Tsagris V; Nika A; Kyriakou D; Kapetanakis I; Harahousou E; Stripeli F; Maltezou H; Tsolia M
J Hosp Infect; 2012 May; 81(1):36-40. PubMed ID: 22463979
[TBL] [Abstract][Full Text] [Related]
9. Influenza outbreak management on a locked behavioral health unit.
Risa KJ; McAndrew JM; Muder RR
Am J Infect Control; 2009 Feb; 37(1):76-8. PubMed ID: 18945518
[TBL] [Abstract][Full Text] [Related]
10. A retrospective observational study of the treatment of a nosocomial infection caused by oseltamivir-resistant influenza virus A with baloxavir marboxil.
Fujita M; Matsumoto H; Inafuku Y; Toyama J; Fujita J
Respir Investig; 2020 Sep; 58(5):403-408. PubMed ID: 32605828
[TBL] [Abstract][Full Text] [Related]
11. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
Gooskens J; Jonges M; Claas EC; Meijer A; van den Broek PJ; Kroes AM
JAMA; 2009 Mar; 301(10):1042-6. PubMed ID: 19255111
[TBL] [Abstract][Full Text] [Related]
12. Experience with oseltamivir in the control of a nursing home influenza B outbreak.
Parker R; Loewen N; Skowronski D
Can Commun Dis Rep; 2001 Mar; 27(5):37-40. PubMed ID: 11260987
[TBL] [Abstract][Full Text] [Related]
13. Combined interventions for mitigation of an influenza A (H1N1) 2009 outbreak in a physical training camp in Beijing, China.
Chu CY; de Silva UC; Guo JP; Wang Y; Wen L; Lee VJ; Li SL; Huang LY
Int J Infect Dis; 2017 Jul; 60():77-82. PubMed ID: 28483722
[TBL] [Abstract][Full Text] [Related]
14. Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation.
Iioka F; Sada R; Maesako Y; Nakamura F; Ohno H
Int J Hematol; 2012 Sep; 96(3):364-9. PubMed ID: 22773299
[TBL] [Abstract][Full Text] [Related]
15. Mass oseltamivir prophylaxis halts pandemic influenza A H1N1 2009 outbreak in a secondary school in Ashanti Region, Ghana.
Asiedu-Bekoe F; Adu DA; Offei A
Ghana Med J; 2012 Dec; 46(4):219-24. PubMed ID: 23661840
[TBL] [Abstract][Full Text] [Related]
16. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.
Tramontana AR; George B; Hurt AC; Doyle JS; Langan K; Reid AB; Harper JM; Thursky K; Worth LJ; Dwyer DE; Morrissey CO; Johnson PD; Buising KL; Harrison SJ; Seymour JF; Ferguson PE; Wang B; Denholm JT; Cheng AC; Slavin M
Emerg Infect Dis; 2010 Jul; 16(7):1068-75. PubMed ID: 20587176
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the use of oseltamivir prophylaxis in the control of influenza outbreaks in long-term care facilities in Alberta, Canada: a retrospective provincial database analysis.
Ye M; Jacobs A; Khan MN; Jaipaul J; Oda J; Johnson M; Doroshenko A
BMJ Open; 2016 Jul; 6(7):e011686. PubMed ID: 27381211
[TBL] [Abstract][Full Text] [Related]
18. Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009.
Lee VJ; Yap J; Tay JK; Barr I; Gao Q; Ho HJ; Tan BH; Kelly PM; Tambyah PA; Kelso A; Chen MI
BMC Infect Dis; 2010 Jun; 10():164. PubMed ID: 20537158
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic oseltamivir during major seasonal influenza H1N1 outbreak might reduce both H1N1 and associated pulmonary aspergillosis in children undergoing haploidentical transplantation.
Jaiswal SR; Bhagwati G; Soni M; Thatai A; Aiyer H; Chakrabarti S
Transpl Infect Dis; 2020 Oct; 22(5):e13309. PubMed ID: 32383345
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
